U.S. flag

An official website of the United States government

NM_000102.4(CYP17A1):c.287G>A (p.Arg96Gln) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 13, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001067683.8

Allele description [Variation Report for NM_000102.4(CYP17A1):c.287G>A (p.Arg96Gln)]

NM_000102.4(CYP17A1):c.287G>A (p.Arg96Gln)

Gene:
CYP17A1:cytochrome P450 family 17 subfamily A member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q24.32
Genomic location:
Preferred name:
NM_000102.4(CYP17A1):c.287G>A (p.Arg96Gln)
HGVS:
  • NC_000010.11:g.102837075C>T
  • NG_007955.1:g.5459G>A
  • NM_000102.4:c.287G>AMANE SELECT
  • NP_000093.1:p.Arg96Gln
  • NC_000010.10:g.104596832C>T
  • NM_000102.3:c.287G>A
  • P05093:p.Arg96Gln
Protein change:
R96Q; ARG96GLN
Links:
UniProtKB: P05093#VAR_073043; OMIM: 609300.0029; dbSNP: rs104894153
NCBI 1000 Genomes Browser:
rs104894153
Molecular consequence:
  • NM_000102.4:c.287G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001232754Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 13, 2024)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A novel point mutation in P450c17 (CYP17) causing combined 17alpha-hydroxylase/17,20-lyase deficiency.

Brooke AM, Taylor NF, Shepherd JH, Gore ME, Ahmad T, Lin L, Rumsby G, Papari-Zareei M, Auchus RJ, Achermann JC, Monson JP.

J Clin Endocrinol Metab. 2006 Jun;91(6):2428-31. Epub 2006 Mar 28.

PubMed [citation]
PMID:
16569739

Molecular study of five Chinese patients with 46XX partial 17a-hydroxylase/17,20-lyase deficiency.

Tian Q, Yao F, Zhang Y, Tseng H, Lang J.

Gynecol Endocrinol. 2012 Mar;28(3):234-8. doi: 10.3109/09513590.2011.593665. Epub 2011 Aug 16.

PubMed [citation]
PMID:
21846181
See all PubMed Citations (9)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001232754.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (9)

Description

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 96 of the CYP17A1 protein (p.Arg96Gln). This variant is present in population databases (rs104894153, gnomAD 0.004%). This missense change has been observed in individuals with autosomal recessive congenital adrenal hyperplasia (PMID: 16569739, 21846181, 23291414, 23466679, 26543560, 28008861). ClinVar contains an entry for this variant (Variation ID: 1802). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CYP17A1 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg96 amino acid residue in CYP17A1. Other variant(s) that disrupt this residue have been observed in individuals with CYP17A1-related conditions (PMID: 8550762, 21340163), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024